IFRA Chair Looks Forward To Post-COVID-19 ‘Revival Of Reason’
Executive Summary
IFRA’s new chairman Hans Holger Gliewe says one possible positive outcome of the COVID-19 pandemic could be that consumers go on putting a premium on scientific expertise after months of reliance on health experts’ advice. The public’s changed perspective could help drive science-based regulatory decision making, a caused long championed by the fragrance and beauty product industries.
You may also be interested in...
With ‘Commercial Health,’ US Essential Business Guidance Expands Well Beyond Supplements
DHS agency’s latest guidance for state, local governments to define essential businesses during pandemic includes “commercial health” and personal care products. Natural Products Association says supplement market is “surging” on its efforts to include the segment in earlier DHS guidance.
2020 US Beauty May Be Headed For Record Declines, But There Are COVID-19 Opportunities
Kline & Company’s worst-case scenario – which it says is looking more and more likely – has the US cosmetics and personal-care market declining by as much as 8.1% in 2020. However, Kline, Mintel and other market intelligence firms say there are opportunities available to companies struggling to weather the COVID-19 storm.
US And Trading Neighbors Advocate Risk-Based, Science-Backed Cosmetics Regs
As European industry’s concerns grow about “politicization” of regulatory programs, the United States-Mexico-Canada Agreement’s cosmetics annex directs regulatory authorities pursuing new rules to give due consideration to scientific and technical guidance documents developed through international collaboration.